GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mydecine Innovations Group Inc (AQSE:MYIG) » Definitions » Cyclically Adjusted FCF per Share

Mydecine Innovations Group (AQSE:MYIG) Cyclically Adjusted FCF per Share : £0.00 (As of Sep. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Mydecine Innovations Group Cyclically Adjusted FCF per Share?

Note: As Cyclically Adjusted FCF per Share is a main component used to calculate Cyclically Adjusted Price-to-FCF. If the month end stock price for this stock is zero, result may not be accurate due to the exchange rate between different shares and the data will not be stored into our database. Selected historical data showed in the calculation section below is only for demostration purpose.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Mydecine Innovations Group's adjusted free cash flow per share for the three months ended in Sep. 2023 was £-0.002. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is £0.00 for the trailing ten years ended in Sep. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2024-06-05), Mydecine Innovations Group's current stock price is £0.0175. Mydecine Innovations Group's Cyclically Adjusted FCF per Share for the quarter that ended in Sep. 2023 was £0.00. Mydecine Innovations Group's Cyclically Adjusted Price-to-FCF of today is .


Mydecine Innovations Group Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Mydecine Innovations Group's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mydecine Innovations Group Cyclically Adjusted FCF per Share Chart

Mydecine Innovations Group Annual Data
Trend Dec13 Aug14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Mydecine Innovations Group Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Mydecine Innovations Group's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Mydecine Innovations Group's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mydecine Innovations Group's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mydecine Innovations Group's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Mydecine Innovations Group's Cyclically Adjusted Price-to-FCF falls into.



Mydecine Innovations Group Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Mydecine Innovations Group's adjusted Free Cash Flow per Share data for the three months ended in Sep. 2023 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=-0.002/125.2304*125.2304
=-0.002

Current CPI (Sep. 2023) = 125.2304.

Mydecine Innovations Group Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201311 0.000 97.182 0.000
201402 0.000 98.051 0.000
201405 -1.500 99.394 -1.890
201408 0.000 99.315 0.000
201412 0.000 98.367 0.000
201503 -17.857 99.789 -22.410
201506 -8.440 100.500 -10.517
201509 -2.815 100.421 -3.510
201512 -0.667 99.947 -0.836
201603 -1.704 101.054 -2.112
201606 -2.357 102.002 -2.894
201609 -0.633 101.765 -0.779
201612 -15.681 101.449 -19.357
201703 -14.490 102.634 -17.680
201706 -12.250 103.029 -14.890
201709 -1.741 103.345 -2.110
201712 -21.667 103.345 -26.256
201803 -6.079 105.004 -7.250
201806 -14.769 105.557 -17.522
201809 -3.581 105.636 -4.245
201812 0.213 105.399 0.253
201903 -2.850 106.979 -3.336
201906 -0.390 107.690 -0.454
201909 -0.697 107.611 -0.811
201912 -0.139 107.769 -0.162
202003 -0.013 107.927 -0.015
202006 -0.874 108.401 -1.010
202009 -0.317 108.164 -0.367
202012 -0.499 108.559 -0.576
202103 -1.256 110.298 -1.426
202106 -0.572 111.720 -0.641
202109 -0.716 112.905 -0.794
202112 -0.561 113.774 -0.617
202203 -0.210 117.646 -0.224
202206 -0.362 120.806 -0.375
202209 -0.034 120.648 -0.035
202212 -0.051 120.964 -0.053
202303 -0.097 122.702 -0.099
202306 -0.051 124.203 -0.051
202309 -0.002 125.230 -0.002

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Mydecine Innovations Group  (AQSE:MYIG) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Mydecine Innovations Group Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Mydecine Innovations Group's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Mydecine Innovations Group (AQSE:MYIG) Business Description

Traded in Other Exchanges
Address
789 West Pender Street, Suite 810, Vancouver, BC, CAN, V6C 1H2
Mydecine Innovations Group Inc is a biopharma and life sciences company engaged in the research, drug development, and clinical trials of psilocybin products.

Mydecine Innovations Group (AQSE:MYIG) Headlines

No Headlines